Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Yun-Ju Huang

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|March 27, 2020
Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cellsKee Siang Lim, Zachary Wei Ern Yong, Huajing Wang, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
Journal of Ovarian Research|March 3, 2026
Deep spatial transcriptomic profiling of ovarian clear cell carcinoma in the real-world settingThang Truong Le, Alice Hsiang-Kuo Yang, Ko-Chen Chen, et al.
Oncogene|December 20, 2017
Dual role of autophagy in hallmarks of cancerShikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, et al.
Communications Biology|July 20, 2023
Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancerXun Hui Yeo, Vignesh Sundararajan, Zhengwei Wu, et al.
Gynecologic Oncology|October 16, 2024
Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trialAiko Ogasawara, Hirokazu Matsushita, Tuan Zea Tan, et al.
Journal of Gynecologic Oncology|December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
Communications Biology|June 22, 2023
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancerXun Hui Yeo, Vignesh Sundararajan, Zhengwei Wu, et al.
Antioxidants & Redox Signaling|April 28, 2020
Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma <i>Via</i> Oxidative Stress and Iron-Sulfur Cluster Biogenesis DeficitWisna Novera, Zheng-Wei Lee, Dawn Sijin Nin, et al.
EMBO Reports|June 17, 2018
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancerJane Antony, Elisa Zanini, Zoe Kelly, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|March 27, 2020
Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cellsKee Siang Lim, Zachary Wei Ern Yong, Huajing Wang, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
Journal of Ovarian Research|March 3, 2026
Deep spatial transcriptomic profiling of ovarian clear cell carcinoma in the real-world settingThang Truong Le, Alice Hsiang-Kuo Yang, Ko-Chen Chen, et al.
Oncogene|December 20, 2017
Dual role of autophagy in hallmarks of cancerShikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, et al.
Communications Biology|July 20, 2023
Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancerXun Hui Yeo, Vignesh Sundararajan, Zhengwei Wu, et al.
Gynecologic Oncology|October 16, 2024
Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trialAiko Ogasawara, Hirokazu Matsushita, Tuan Zea Tan, et al.
Journal of Gynecologic Oncology|December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
Communications Biology|June 22, 2023
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancerXun Hui Yeo, Vignesh Sundararajan, Zhengwei Wu, et al.
Antioxidants & Redox Signaling|April 28, 2020
Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma <i>Via</i> Oxidative Stress and Iron-Sulfur Cluster Biogenesis DeficitWisna Novera, Zheng-Wei Lee, Dawn Sijin Nin, et al.
EMBO Reports|June 17, 2018
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancerJane Antony, Elisa Zanini, Zoe Kelly, et al.
Pageof 9